Terms ending in 2032
Ironshore Pharmaceuticals & Development, Inc.
Every in-force patent on Ironshore Pharmaceuticals & Development, Inc.'s record whose computed term ends in 2032, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 8,916,588 | Methods for Treatment of Attention Deficit Hyperactivity Disorder In force · Medium confidence | Ironshore Pharmaceuticals & Development, Inc. | In force | Medium confidence | |
| US 8,927,010 | Compositions for Treatment of Attention Deficit Hyperactivity Disorder In force · Medium confidence | Ironshore Pharmaceuticals & Development, Inc. | In force | Medium confidence | |
| US 9,023,389 | Compositions for Treatment of Attention Deficit Hyperactivity Disorder In force · Low confidence | Ironshore Pharmaceuticals & Development, Inc. | In force | Low confidence | |
| US 9,028,868 | Methods and Compositions for Treatment of Attention Deficit Disorder In force · Medium confidence | Ironshore Pharmaceuticals & Development, Inc. | In force | Medium confidence | |
| US 9,034,902 | Methods for Treatment of Attention Deficit Hyperactivity Disorder In force · Low confidence | Ironshore Pharmaceuticals & Development, Inc. | In force | Low confidence | |
| US 9,119,809 | Compositions for Treatment of Attention Deficit Hyperactivity Disorder In force · Medium confidence | Ironshore Pharmaceuticals & Development, Inc. | In force | Medium confidence | |
| US 9,283,214 | Compositions for Treatment of Attention Deficit Hyperactivity Disorder In force · Medium confidence | Ironshore Pharmaceuticals & Development, Inc. | In force | Medium confidence | |
| US 9,289,394 | Compositions for Treatment of Attention Deficit Hyperactivity Disorder In force · Medium confidence | Ironshore Pharmaceuticals & Development, Inc. | In force | Medium confidence | |
| US 9,498,447 | Compositions for Treatment of Attention Deficit Hyperactivity Disorder In force · Medium confidence | Ironshore Pharmaceuticals & Development, Inc. | In force | Medium confidence | |
| US 9,511,032 | Compositions for Treatment of Attention Deficit Hyperactivity Disorder In force · Medium confidence | Ironshore Pharmaceuticals & Development, Inc. | In force | Medium confidence | |
| 13 more term ends in 2032 · Pro | |||||
10 of 23 patents shown. Soonest term end first, then patent number.
Pro members see all 23.
22 of these are in force and held by Ironshore Pharmaceuticals & Development, Inc..
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.